$CAC

CAMDEN NATIONAL CORP

No enriched coverage for $CAC in the last 7 days.

No SEC Form 4 filings for $CAC in the last 30 days.

Med

Camden National (CAC) CEO awarded 6,919 restricted shares under 2022 plan

Camden National Corp CEO Simon Griffiths was granted 6,919 restricted shares of Common Stock under the company's 2022 Equity and Incentive Plan. These shares, valued at $50.67 each for reporting purposes, will vest pro rata over three years, contingent on his continued employment. Following this grant, Mr. Griffiths' direct holdings total 44,399 shares, including 31,098 restricted units still subject to vesting.

Camden National EVP granted 1,281 restricted shares | CAC Insider Trading

Camden National Corp EVP Ryan A. Smith was granted 1,281 restricted shares of common stock valued at $50.67 per share under the company's 2022 Equity and Incentive Plan. These awards will vest pro-rata over three years, contingent on his continued employment. Following this grant, Smith directly holds 24,276 shares, including additional restricted units subject to vesting and forfeiture conditions.

Camden National (CAC) EVP receives 1,281 restricted stock awards

Camden National Corp EVP Patricia A. Rose was granted 1,281 shares of common stock valued at $50.67 per share as restricted stock awards. These awards, part of the company's 2022 Equity and Incentive Plan, are set to vest pro-rata over the next three years, contingent on her continued employment. Following this grant, Rose's direct holdings total 28,923.593 common shares, including both vested and unvested restricted units.